Home Biosimilar Antibodies Protein Tyrosine Kinase EGFR antibody Coprelotamab (Anti-ERBB2 / HER2 / CD340) For research use only.
Not for use in humans.

Coprelotamab (Anti-ERBB2 / HER2 / CD340)

Synonyms: null

Coprelotamab (Anti-ERBB2 / HER2 / CD340) is humanized monoclonal antibody targated against HER2 with the potential to treat breast cancer. MW : 145.36 KD.

Coprelotamab (Anti-ERBB2 / HER2 / CD340)

Purity & Quality Control

Choose Selective EGFR Inhibitors

Name Citation EGFR/ErbB1 HER2/ErbB2 ErbB3 ErbB4 mutant EGFR Others
Saracatinib (AZD0530) 291 c-Src,c-YES,LCK
Canertinib (CI-1033) 48
AG-490 129 JAK2 (V617F)
CP-724714 108
WZ4002 34
Sapitinib (AZD8931) 46
CUDC-101 22 HDAC,HDAC1,HDAC6
AG-1478 96
PD153035 HCl 17
Pelitinib (EKB-569) 11 Src,MEK/ERK,Raf
AEE788 (NVP-AEE788) 13 c-Abl,FLT1,c-Fms
AC480 (BMS-599626) 10
AP26113-analog (ALK-IN-1) 4 ALK,IGF1R,INSR
WZ3146 2
Allitinib tosylate 16
Rociletinib (CO-1686) 36
Varlitinib 8
Icotinib (BPI-2009H) 9
TAK-285 4 MEK1,Aurora B,LCK
WHI-P154 11 Src,VEGFR,JAK3
Daphnetin 4 PKA,PKC
PD168393 6
CNX-2006 2
Tyrphostin 9 1 PDGFR
AG-18 1
Icotinib Hydrochloride 0
HS-10296 hydrochloride 0
MTX-531 0 PI3Kα
Avitinib maleate 0 BTK
limertinib 0
AG 825 0 PDGFR
4-AMino-1-phenylpyrazolo[3,4-d]pyriMidine 0
AST-1306 0
ErbB2 inhibitor 0
Tuxobertinib (BDTX-189) 2 RIPK2,BLK
Epertinib hydrochloride 0
JND3229 0 EGFR C797S
BI-4020 1
Tyrphostin AG-528 0
AG 556 0
Canertinib dihydrochloride 8
EGFR Inhibitor 3 Microtubules
SU5214 0 VEGFR2
RG 13022 0
TQB3804 0
zipalertinib (TAS6417) 3 TXK,BMX
Pyrotinib dimaleate 4
PD153035 14
AG 494 0
AG 555 0
Theliatinib (HMPL-309) 0
Avitinib (Abivertinib) 2 JAK3,BTK
Lazertinib 6 Del19,L85R
Lifirafenib (BGB-283) 6 WT A-RAF,C-RAF (Y340/341D),BRAF(V600E)
Nazartinib (EGF816) 6
Zorifertinib (AZD3759) 6
CL-387785 (EKI-785) 4
Poziotinib 34
AZ5104 4 ACK1,BLK,BRK
AV-412 free base 0
HER2-Inhibitor-1
WZ8040
Genistein topo II
Rezivertinib
BDTX-1535
Falnidamol
BLU-945
Sunvozertinib (DZD9008)
CH7233163
Licochalcone D NF-κB,PARP,Caspase
Alflutinib (Furmonertinib) mesylate CYP3A4
(Rac)-JBJ-04-125-02
Tyrphostin AG30 (AG30)
AG-1557
AG99
MTX-211 PI3K
RG14620 ABCG2
Almonertinib (HS-10296)
Cyasterone
Norcantharidin c-Met
Naquotinib(ASP8273)
EAI045
Olmutinib (BI 1482694) BTK
Butein
Chrysophanic Acid mTOR
EGCG ((-)-Epigallocatechin Gallate) DNMT,telomerase,FASN
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Coprelotamab (Anti-ERBB2 / HER2 / CD340) is humanized monoclonal antibody targated against HER2 with the potential to treat breast cancer. MW : 145.36 KD.

Product Details

CAS No. 2348469-84-9
Molecular Weight 145.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Coprelotamab (Anti-ERBB2 / HER2 / CD340) | Coprelotamab (Anti-ERBB2 / HER2 / CD340) supplier | purchase Coprelotamab (Anti-ERBB2 / HER2 / CD340) | Coprelotamab (Anti-ERBB2 / HER2 / CD340) cost | Coprelotamab (Anti-ERBB2 / HER2 / CD340) manufacturer | order Coprelotamab (Anti-ERBB2 / HER2 / CD340) | Coprelotamab (Anti-ERBB2 / HER2 / CD340) distributor